Physician profile
Michael Schalet
NPI 1275679649
$641.05
in general payments reported to CMS, 2019-2025
20 companies · $18.76 in 2025
The $18.76 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $137 · 2021: $114 · 2022: $63.74 · 2023: $85.82 · 2025: $18.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $93.35 | 2019-2022 | |
| Amarin Pharma, INC. | $58.37 | 2019-2021 | |
| Medtronic, INC. | $56.62 | 2023 | Gi Genius |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.00 | 2019 | |
| Allergan, INC. | $48.92 | 2019 | |
| Amgen INC. | $46.19 | 2020-2025 | Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $41.58 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $29.21 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $28.95 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.65 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $26.12 | 2019-2020 | |
| Braintree Laboratories, INC. | $19.44 | 2019 | |
| Olympus America INC. | $17.02 | 2019 | |
| Janssen Biotech, INC. | $16.19 | 2023 | Stelara |
| Ferring Pharmaceuticals INC. | $14.34 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $13.64 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.57 | 2021 | |
| Baxter Healthcare | $13.01 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Gilead Sciences, INC. | $12.50 | 2020 | |
| Esperion Therapeutics, INC. | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schalet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.